Ｍ－サンバイオ：Analytical Results of Phase 2b Study in the U.S. Evaluating SB623, a Regenerative Cell Medicine for the Treatment of Patients with Stroke Program - 有報キャッチャー

Ｍ－サンバイオ（4592）　Analytical Results of Phase 2b Study in the U.S. Evaluating SB623, a Regenerative Cell Medicine for the Treatment of Patients with Stroke Program 2020/04/20

/-

読み込み中…